BRUSSELS, BELGIUM / RankWire.AI / – European Commission has committed to purchasing €2.1 million worth of PCR tests to support the response to the ongoing Bundibugyo Ebola outbreak. These open-platform tests aim to enhance detection efforts and bolster laboratory capabilities amid the crisis. The procurement was coordinated with assistance from the European Health and Digital Executive Agency, with deliveries set to commence in August. This initiative will increase diagnostic resources as health officials contend with rising case numbers in the Democratic Republic of the Congo.
World Health Organization’s Hub for Global Health Emergencies Logistics in Dubai will receive the PCR tests. WHO will oversee their distribution to regions engaged in the Ebola response. PCR testing is vital for infection confirmation because laboratories can handle large sample volumes with high precision. Additionally, the equipment integrates with existing laboratory infrastructure. Rapid test results allow health teams to quickly identify infected individuals, facilitate proper care and isolation, and conduct effective contact tracing around confirmed cases.
The latest procurement complements a separate European Commission initiative of €2.5 million for rapid molecular point-of-care tests and testing devices. These supplies are intended to assist the Africa Centres for Disease Control and Prevention. In total, the two agreements bring the European Commission’s current diagnostic support efforts to €4.6 million. These measures are part of a broader European response to the Bundibugyo virus outbreak, which has increasingly strained healthcare systems in affected areas of Central and East Africa.
Expansion of diagnostic tools as outbreak intensifies
By August 12, WHO reported 4,665 confirmed Ebola cases and 2,184 deaths in the Democratic Republic of the Congo. The outbreak has affected 54 health zones across six provinces, including Ituri, North Kivu, South Kivu, Haut-Uélé, Tshopo, and Bas-Uélé. WHO characterized this as the largest Ebola outbreak ever recorded in the country. Continued transmission remains intense, with interconnected geographic clusters fueling ongoing spread within the affected regions.
On August 14, WHO maintained its highest national risk level for the Democratic Republic of the Congo. The regional risk for neighboring nations was assessed as high, while the risk for other countries was deemed low. After its second meeting, the WHO International Health Regulations Emergency Committee issued updated temporary guidance on August 24, covering surveillance, case detection, infection prevention, clinical management, community engagement, and measures concerning domestic mobility and large gatherings.
European support total reaches €493 million amid ongoing crisis
The European Commission announced the allocation of €493 million for emergency aid, vaccines, treatment, and health-security measures in the Great Lakes and Uganda regions. European health authorities have also contributed to surveillance efforts, laboratory work, and preparedness activities during the outbreak. The European Centre for Disease Prevention and Control continues to classify the risk to Europeans as very low, citing the need for direct contact with infectious body fluids and the low probability of sustained transmission within Europe.
The Bundibugyo outbreak remains classified as a public health emergency of international concern, a designation declared by WHO on May 17. Unlike the more common Zaire ebolavirus, the Bundibugyo virus currently lacks an approved vaccine or targeted treatment. WHO emphasizes the importance of surveillance, rapid diagnosis, patient isolation, clinical care, infection control, and contact monitoring. The recent PCR procurement by the European Commission enhances laboratory capacity to support these core response activities while WHO and Africa CDC coordinate health interventions with national authorities in affected and neighboring countries.